Finally, it should be noted that levels of soluble VEGFR1 and VEGFR2, the former of which was shown to be altered in the brain of AD patients [45], modulate angiogenic response of VEGF and, possibly, VEGF levels in CSF. The gene discussed is FLT1; the disease is Alzheimer disease.